Reuters logo
4 months ago
BRIEF-Oncolys Biopharma signs joint research agreement for next generation telomelysin with Osaka University
March 28, 2017 / 6:26 AM / 4 months ago

BRIEF-Oncolys Biopharma signs joint research agreement for next generation telomelysin with Osaka University

1 Min Read

March 28 (Reuters) - Oncolys Biopharma Inc:

* Says it signed a joint research agreement for design and production of next generation telomer ricin and next generation telome scan with Osaka University

Source text in Japanese: goo.gl/PdVgvK

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below